Good Days is excited to announce that the 2020 Re-Enrollment Campaign is now open! Please click HERE to re-enroll for assistance. Due to high call volume during this time, we highly encourage you to utilize our online tool for re-enrollment.

 
Diseases Covered

Chronic Noninfectious Uveitis

Includes: Chorioretinal Inflammation, Harada's Disease, Panuveitis, Posterior Cyclitis, Vogt-Koyanagi Syndrome
All pictures shown are used for illustrative purposes only.

Program Status

open

Apply Now

Assistance Amount

$ 1,650

Ask your Good Days Patient Care Navigator for more information.

Eligibility Criteria

  • Patient must be diagnosed with a covered disease and program must be accepting enrollments
  • Patient must have a valid Social Security number to apply for assistance and receive treatment in the United States
  • Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis
  • Patient is required to have valid Medicare or Military insurance coverage
  • Patient income level must be at or below 500% of the Federal Poverty Level (FPL)

Apply Now

Support Organizations

These organizations do not offer co-pay assistance, but they offer valuable information and support.

  • Dexamethasone
  • Durezol
  • Humira
  • Kenalog-40
  • Orapred ODT
  • Ozurdex
  • Prednisolone
  • Prednisone
  • Retisert
  • Triesence
  • Yutiq

Uveitis is caused by inflammatory responses inside the eye. The disease will cause symptoms, such as decreased vision, pain, light sensitivity, and increased floaters. (Source: NIH US National Library of Medicine)

Support Organizations

These organizations do not offer co-pay assistance, but they offer valuable information and support.

Medications Covered

  • Dexamethasone
  • Durezol
  • Humira
  • Kenalog-40
  • Orapred ODT
  • Ozurdex
  • Prednisolone
  • Prednisone
  • Retisert
  • Triesence
  • Yutiq

Disease Description

Uveitis is caused by inflammatory responses inside the eye. The disease will cause symptoms, such as decreased vision, pain, light sensitivity, and increased floaters. (Source: NIH US National Library of Medicine)